阶梯策略、三线治疗与创伤性脑损伤患者结局:Triple-T TBI研究
该国际多中心回顾性观察性队列研究纳入16个ICU中408例因颅内高压需至少一种三线治疗(巴比妥类代谢抑制、二线去骨瓣减压术、轻度低温)的成人TBI患者,评估三线治疗的临床实践、使用时机及其与ICU死亡率和3个月神经功能结局的关联。结果显示二线去骨瓣减压术最常用(297例,72.8%),与ICU死亡率降低相关(OR 0.34,95%CI 0.14-0.78,p=0.012)且神经功能结局更好(p=0.047);巴比妥类与ICU死亡率升高相关(OR 3.05,95%CI 1.43-6.49,p=0.004)且神经功能结局更差(p=0.032)。224例(55%)患者接受了符合指南的干预,与结局改善呈非显著趋势。作者认为三线治疗前阶梯策略不常使用,二线去骨瓣减压术较其他治疗更常实施且与死亡率和神经功能结局改善相关,三线治疗处方前遵循指南的获益有待进一步评估。
要点
- 二线去骨瓣减压术是最常用的三线治疗(297/408例,72.8%),与ICU死亡率降低相关(OR 0.34,95%CI 0.14-0.78,p=0.012)。
- 巴比妥类治疗与ICU死亡率升高相关(OR 3.05,95%CI 1.43-6.49,p=0.004),且神经功能结局更差(p=0.032)。
- 仅224例(55%)患者在三线治疗前接受了符合指南的干预,与结局改善呈非显著趋势。
- 研究结论认为三线治疗前阶梯策略在重型TBI后不常使用,二线去骨瓣减压术较其他治疗更常实施。
适用人群与场景
- 16个ICU中408例成人TBI患者,需在ICU期间使用至少一种三线治疗(巴比妥类代谢抑制、二线去骨瓣减压术或轻度低温)控制颅内高压。
处置流程与药物剂量
- 三线治疗包括:巴比妥类代谢抑制、二线去骨瓣减压术、轻度低温,用于控制ICU期间颅内高压。
- 二线去骨瓣减压术在408例中实施297例(72.8%),为最常用的三线治疗。
研究设计与关键结果
- 国际多中心回顾性观察性队列研究,16个ICU,408例成人TBI患者,需至少一种三线治疗。
- 二线去骨瓣减压术使用297例(72.8%),与ICU死亡率降低相关(OR 0.34,95%CI 0.14-0.78,p=0.012),神经功能结局更好(p=0.047)。
- 巴比妥类与ICU死亡率升高相关(OR 3.05,95%CI 1.43-6.49,p=0.004),神经功能结局更差(p=0.032)。
- 224例(55%)患者接受符合指南的干预,与结局改善呈非显著趋势。
证据类型、等级与局限
- 证据类型:国际多中心回顾性观察性队列研究。
- 作者结论:三线治疗前阶梯策略不常使用;二线去骨瓣减压术较其他治疗更常实施且与死亡率和神经功能结局改善相关;三线治疗处方前遵循指南的获益有待进一步评估。
对床旁实践的改变
- 作者认为二线去骨瓣减压术的使用与ICU死亡率和神经功能结局改善相关。
- 作者认为巴比妥类的使用与ICU死亡率升高和神经功能结局恶化相关。
- 作者认为三线治疗前阶梯策略在重型TBI后不常使用,三线治疗处方前遵循指南的获益有待进一步评估。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate the clinical practice and timing of use of tier-three therapies (TTT) after traumatic brain injury (TBI), and to explore their association with intensive care unit (ICU) mortality and 3 months neurological outcome.
METHODS: International multicenter, retrospective, observational, cohort study performed in 16 ICUs including 408 adult TBI patients requiring at least one of the TTT [i.e. metabolic suppression with barbiturates, secondary decompressive craniectomy (DC), and mild hypothermia] for the control of intracranial hypertension during the ICU stay.
RESULTS: Among 408 adult TBI patients, secondary DC was the most frequent TTT utilized (n = 297, 72.8%), and was associated with reduced ICU mortality [Odds Ratio, OR 0.34 (95% Confidence Interval, CI 0.14-0.78) p = 0.012] and better neurological outcome (p = 0.047), whereas barbiturates were associated with increased ICU mortality [OR: 3.05 (95% CI 1.43-6.49); p = 0.004) and worse neurological outcome (p = 0.032). Two hundred and twenty-four (55%) patients received interventions in adherence to guidelines, which was associated with a non-significant trend towards better outcomes.
CONCLUSIONS: The staircase approach before the use of TTT was not often utilized after severe TBI. Secondary DC was performed more often than other treatments and its use was associated with improved mortality and neurological outcome. The benefits of adherence to guidelines before TTT prescription should be further evaluated.
参考来源
- Picetti E, Galarza L, Arroyo Diez M, et al. Staircase strategy, tier-three therapies, and effects on outcome in traumatic brain injured patients: the Triple-T TBI study. Intensive Care Med. 2025. PMID: 40227321. doi:10.1007/s00134-025-07864-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。